Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia

European Journal of Haematology

Volumn 89, Issue 4, 2012, Pages 288-293

  Brady, Anna ^a   Gibson, Sarah ^b   Rybicki, Lisa ^b   Hsi, Eric ^b   Saunthararajah, Yogen ^a   Sekeres, Mikkael A ^a   Tiu, Ramon ^a   Copelan, Edward ^a   Kalaycio, Matt ^a   Sobecks, Ronald ^a   Bates, Jennifer ^a   Advani, Anjali S ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute myeloid leukemia; Phosphorylation; Prognosis; STAT5

Indexed keywords

STAT5 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CYTOGENETICS; DEATH; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; REMISSION; RISK;

FMS-LIKE TYROSINE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID, ACUTE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RISK FACTORS; STAT5 TRANSCRIPTION FACTOR;

EID: 84866416397     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2012.01825.x     Document Type: Article

References (17)

1. Yu H, Pardoll D, Jove R STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009;9:798-809.
2. Baumgartner C, Cerny-Reiterer S, Sonneck K, et al. Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V. Am J Pathol 2009;175:2416-29.
3. Heuser M, Sly LM, Argiropoulos B, et al. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Blood 2009;114:3983-93.
4. Buitenhaus M, Coffer P, Koenderman L Signal transducer and activator of transcription 5 (STAT5). Int J Biochem Cell Biol 2004;36:2120-4.
5. Byrd, JC, Mrozek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer and leukemia group B (CALGB 8461). Blood 2002;100:4325-36.
6. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003;21:4642-9.
7. Darnell JE Jr, Kerr IM, Stark GR Jak-STAT pathways and transcription activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-21.
8. O'Sullivan LA, Liongue S, Lewis RS, Stephenson SE, Ward AC Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol 2007;44:2497-506.
9. Ward AC, Touw I, Yoshimura A The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 2000;95:119-29.
10. Debierre-Grockiego F Anti-apoptotic role of STAT5 in hematopoietic cells and in the pathogenesis of malignancies. Apoptosis 2004;9:717-28.
11. Lord JD, McIntosh BC, Greenberg PD, Nelson BH The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-s, and bcl-x genes through the trans-activation domain of STAT5. J Immunol 2000;164:2533-41.
12. Prade-Houdellier N, Frebet E, Demur C, et al. Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells. Leukemia 2007;21:2304-10.
13. Obermann EC, Arber C, Jotterand M, Tichelli A, Hirschmann P, Tzankov A Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia. Ann Hematol 2010;89:663-9.
14. Bunting KD, Xie XY, Warshawsky I, Hsi ED Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD. Blood 2007;110:2775-6.
15. Aboudola S, Murugesan G, Szpurka H, et al. Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation. Am J Surg Pathol 2007;31:233-9.
16. Xia Z, Baer MR, Block AW, Baumann H, Wetzler M Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. Cancer Res 1998;58:3173-80.
17. Baskiewicz-Masiuk M, Paczkowski M, Machalinski B The influence of antisense oligonucleotides against STAT5 on the regulation of normal hematopoiesis in a bone marrow model. Cell Prolif 2004;37:231-45.